Banelli相关文献与解析，生知库 | 链接生命科学的每一步

Boutros, Andrea; Carosio, Roberta; Campanella, Dalila; Banelli, Barbara; Morabito, Anna; Pistillo, Maria Pia; Croce, Elena; Queirolo, Paola; Tanda, Enrica Teresa; Raposio, Edoardo; Fontana, Vincenzo; Spagnolo, Francesco

黑色素瘤

PD-1

发表日期：2024

文献求助收藏

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells

Guadecitabine通过调控T细胞、髓源性抑制细胞和NK细胞，增强小鼠黑色素瘤对联合抗CTLA-4和抗PD-1治疗的反应。

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:11.4

doi:10.1186/s13046-023-02628-x

Adriana Amaro # ，Francesco Reggiani # ，Daniela Fenoglio # ，Rosaria Gangemi ，Anna Tosi ，Alessia Parodi ，Barbara Banelli ，Valentina Rigo ，Luca Mastracci ，Federica Grillo ，Alessandra Cereghetti ，Aizhan Tastanova ，Adhideb Ghosh ，Fabio Sallustio ，Laura Emionite ，Antonio Daga ，Tiziana Altosole ，Gilberto Filaci ，Antonio Rosato ，Mitchell Levesque ，Michele Maio ，Ulrich Pfeffer ，Michela Croce

The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors

PD-1和PD-L1单核苷酸基因变异在接受PD-1抑制剂治疗的晚期黑色素瘤患者中的预测和预后作用

期刊:ImmunoOncology and Technology

影响因子:

doi:10.1016/j.iotech.2023.100408

Boutros, A; Carosio, R; Campanella, D; Spagnolo, F; Banelli, B; Morabito, A; Pistillo, M P; Croce, E; Cecchi, F; Pronzato, P; Queirolo, P; Raposio, E; Fontana, V; Tanda, E T

A Multidrug Approach to Modulate the Mitochondrial Metabolism Impairment and Relative Oxidative Stress in Fanconi Anemia Complementation Group A

采用多药疗法调节范康尼贫血互补组 A 患者的线粒体代谢障碍和相对氧化应激

期刊:Metabolites

影响因子:3.4

doi:10.3390/metabo12010006

Enrico Cappelli, Nadia Bertola, Silvia Bruno, Paolo Degan, Stefano Regis, Fabio Corsolini, Barbara Banelli, Carlo Dufour, Silvia Ravera

Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis

间皮瘤患者胸腔积液中可溶性PD-L1的特征分析：对免疫反应和预后的潜在影响

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-020-03457-7

Carosio, Roberta; Fontana, Vincenzo; Mastracci, Luca; Ferro, Paola; Grillo, Federica; Banelli, Barbara; Canessa, Pier Aldo; Dessanti, Paolo; Vigani, Antonella; Morabito, Anna; Pfeffer, Ulrich; Poggi, Alessandro; Roncella, Silvio; Pistillo, Maria Pia

IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade

IFN-γ 上调间皮瘤细胞中膜性和可溶性 PD-L1 的表达：对 PD-1/PD-L1 阻断疗法临床疗效的潜在影响

期刊:Cellular & Molecular Immunology

影响因子:19.8

doi:10.1038/s41423-019-0245-x

Pistillo, Maria Pia; Carosio, Roberta; Banelli, Barbara; Morabito, Anna; Mastracci, Luca; Ferro, Paola; Varesano, Serena; Venè, Roberta; Poggi, Alessandro; Roncella, Silvio

Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4(+) tumor infiltrating lymphocytes and their in situ localization

转移性黑色素瘤患者对伊匹木单抗治疗的反应：CTLA-4(+)肿瘤浸润淋巴细胞及其原位定位的潜在相关性

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-020-02494-y

Mastracci, Luca; Fontana, Vincenzo; Queirolo, Paola; Carosio, Roberta; Grillo, Federica; Morabito, Anna; Banelli, Barbara; Tanda, Enrica; Boutros, Andrea; Dozin, Beatrice; Gualco, Marina; Salvi, Sandra; Romani, Massimo; Spagnolo, Francesco; Poggi, Alessandro; Pistillo, Maria Pia

Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study

可溶性 CTLA-4 作为接受伊匹木单抗治疗的转移性黑色素瘤患者的有利预测性生物标志物：一项意大利黑色素瘤协作组研究

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-018-2258-1

Pistillo, Maria Pia; Fontana, Vincenzo; Morabito, Anna; Dozin, Beatrice; Laurent, Stefania; Carosio, Roberta; Banelli, Barbara; Ferrero, Francesca; Spano, Laura; Tanda, Enrica; Ferrucci, Pier Francesco; Martinoli, Chiara; Cocorocchio, Emilia; Guida, Michele; Tommasi, Stefania; De Galitiis, Federica; Pagani, Elena; Antonini Cappellini, Gian Carlo; Marchetti, Paolo; Quaglino, Pietro; Fava, Paolo; Osella-Abate, Simona; Ascierto, Paolo Antonio; Capone, Mariaelena; Simeone, Ester; Romani, Massimo; Spagnolo, Francesco; Queirolo, Paola

黑色素瘤

发表日期：2019

文献求助收藏

Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells

靶向组蛋白去甲基化酶KDM5A和KDM6B可抑制替莫唑胺耐药胶质母细胞瘤细胞的增殖

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers11060878

Romani, Massimo; Daga, Antonio; Forlani, Alessandra; Pistillo, Maria Pia; Banelli, Barbara

Performance Analysis of Centralized Cooperative Schemes for Compressed Sensing

集中式协作压缩感知方案的性能分析

Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma

PD-1单核苷酸基因变异与转移性黑色素瘤风险之间的关联

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells

Guadecitabine通过调控T细胞、髓源性抑制细胞和NK细胞，增强小鼠黑色素瘤对联合抗CTLA-4和抗PD-1治疗的反应。

The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors

PD-1和PD-L1单核苷酸基因变异在接受PD-1抑制剂治疗的晚期黑色素瘤患者中的预测和预后作用

A Multidrug Approach to Modulate the Mitochondrial Metabolism Impairment and Relative Oxidative Stress in Fanconi Anemia Complementation Group A

采用多药疗法调节范康尼贫血互补组 A 患者的线粒体代谢障碍和相对氧化应激

Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis

间皮瘤患者胸腔积液中可溶性PD-L1的特征分析：对免疫反应和预后的潜在影响

IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade

IFN-γ 上调间皮瘤细胞中膜性和可溶性 PD-L1 的表达：对 PD-1/PD-L1 阻断疗法临床疗效的潜在影响

Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4(+) tumor infiltrating lymphocytes and their in situ localization

转移性黑色素瘤患者对伊匹木单抗治疗的反应：CTLA-4(+)肿瘤浸润淋巴细胞及其原位定位的潜在相关性

Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study

可溶性 CTLA-4 作为接受伊匹木单抗治疗的转移性黑色素瘤患者的有利预测性生物标志物：一项意大利黑色素瘤协作组研究

Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells

靶向组蛋白去甲基化酶KDM5A和KDM6B可抑制替莫唑胺耐药胶质母细胞瘤细胞的增殖